Scope Fluidics SA Cash Flow Conversion Efficiency

Latest as of September 2025: -0.102x

Scope Fluidics SA cash flow conversion efficiency. Based on the latest financial reports, Scope Fluidics SA (SCP) has a cash flow conversion efficiency ratio of -0.102x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-11.75 Million ≈ $-3.23 Million USD) by net assets (zł115.43 Million ≈ $31.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Scope Fluidics SA (SCP) total market value for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of Scope Fluidics SA (2015–2024)

Cash flow conversion efficiency of Scope Fluidics SA from 2015 to 2024. This chart illustrates how Scope Fluidics SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Scope Fluidics SA for real-time trading data and today's change.

Scope Fluidics SA Cash Flow Conversion Ratio Explained

Scope Fluidics SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Scope Fluidics SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Scope Fluidics SA ranked by their cash flow conversion efficiency. Review free cash flow generation of Scope Fluidics SA to assess how much free cash flow the company generates relative to operating cash flow.

Company Cash Flow Conversion Efficiency
Butterfly Gandhimathi Appliances Limited
NSE:BUTTERFLY
0.033x
Mosa Industrial Corp
TW:4564
0.027x
Twinhead International Corp
TW:2364
0.054x
ADDvise Group B
ST:ADDV-B
0.032x
Feng Ching Metal
TWO:2061
-0.030x
Iceland Seafood International hf.
IC:ICESEA
0.051x
Consolidated Finvest & Holdings Limited
NSE:CONSOFINVT
-0.002x
RF Acquisition Corp II Unit
NASDAQ:RFAIU
-0.006x

Annual Cash Flow Conversion Efficiency for Scope Fluidics SA (2015–2024)

The table below shows the annual cash flow conversion efficiency of Scope Fluidics SA from 2015 to 2024. Also see Scope Fluidics SA (SCP) total assets for a full breakdown of the balance sheet.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 zł146.35 Million
≈ $40.28 Million
zł-25.10 Million
≈ $-6.91 Million
-0.172x +27.15%
2023-12-31 zł80.93 Million
≈ $22.27 Million
zł-19.06 Million
≈ $-5.24 Million
-0.235x -178.45%
2022-12-31 zł332.97 Million
≈ $91.64 Million
zł-28.16 Million
≈ $-7.75 Million
-0.085x +94.44%
2021-12-31 zł14.58 Million
≈ $4.01 Million
zł-22.19 Million
≈ $-6.11 Million
-1.522x -215.52%
2020-12-31 zł33.09 Million
≈ $9.11 Million
zł-15.96 Million
≈ $-4.39 Million
-0.482x +6.93%
2019-12-31 zł20.22 Million
≈ $5.56 Million
zł-10.48 Million
≈ $-2.88 Million
-0.518x -23.38%
2018-12-31 zł12.81 Million
≈ $3.52 Million
zł-5.38 Million
≈ $-1.48 Million
-0.420x -43.76%
2017-12-31 zł16.88 Million
≈ $4.64 Million
zł-4.93 Million
≈ $-1.36 Million
-0.292x +57.84%
2016-12-31 zł5.58 Million
≈ $1.53 Million
zł-3.87 Million
≈ $-1.06 Million
-0.693x -966.74%
2015-12-31 zł6.70 Million
≈ $1.84 Million
zł535.69K
≈ $147.43K
0.080x --

About Scope Fluidics SA

WAR:SCP Poland Diagnostics & Research
Market Cap
$108.48 Million
zł394.17 Million PLN
Market Cap Rank
#18696 Global
#141 in Poland
Share Price
zł144.60
Change (1 day)
-2.69%
52-Week Range
zł113.00 - zł156.40
All Time High
zł341.00
About

Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. The company offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is based in Warsaw, Poland.